VR Logo

Unrated

Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan download report


1 Lakh

Investment declined to
₹ 0.87 Lakh

₹ 10000

Monthly SIP Declined to
₹ 1.05 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Aditya Birla SL Pharma & Healthcare Fund Reg-G -17.21 -0.06 0.00 -2.58 -10.76 -17.21 -13.28 -- -- -- --
S&P BSE Healthcare TRI -17.33 -0.25 0.32 -3.79 -11.02 -17.33 -15.06 -- -- -- --
Equity: Sectoral-Pharma -15.90 -0.22 0.19 -3.23 -10.37 -15.90 -12.78 -- -- -- --
Rank within category 13 5 12 3 10 13 6 -- -- -- --
Number of funds in category 15 15 15 15 15 15 12 8 4 3 3

As on 30-Jun-2022

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jul-19 -13.28 -- -- 2.57% 470
Nippon India Pharma Fund
Unrated
Jun-04 -14.60 22.43 15.19 1.95% 4,516
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund  | Invest Now
Unrated
Jul-18 -12.13 22.98 -- 2.14% 2,316
Mirae Asset Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jul-18 -10.53 26.04 -- 2.10% 1,692
SBI Healthcare Opportunities Fund  | Invest Online
Unrated
Jul-99 -13.38 22.43 9.76 2.13% 1,638

Best & Worst Performance

Best Performance Worst Performance
Return (%) Period Return (%) Period
Week 19.98 01-Apr-2020 - 09-Apr-2020 -12.18 11-Mar-2020 - 18-Mar-2020
Month 29.68 25-Mar-2020 - 24-Apr-2020 -20.14 20-Feb-2020 - 23-Mar-2020
Quarter 37.72 23-Mar-2020 - 22-Jun-2020 -12.58 17-Mar-2022 - 17-Jun-2022
Year 69.83 23-Mar-2020 - 23-Mar-2021 -13.62 17-Jun-2021 - 17-Jun-2022

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Aditya Birla SL Pharma & Healthcare Fund Reg-G -- -- -- -- -- --
S&P BSE Healthcare TRI* 20.60 22.31 0.77 1.52 -- --
Equity: Sectoral-Pharma* 22.83 20.27 0.96 1.93 0.89 4.17
Rank within category -- -- -- -- -- --
Number of funds in category -- -- -- -- -- --

The Risk Measures have been calculated using calendar month returns for the last three years.

As on

* As on 31-May-2022

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 25
Top 10 Stocks (%) 68.15
Top 5 Stocks (%) 46.87
Top 3 Sectors (%) 98.07
Portfolio P/B Ratio 4.07
Portfolio P/E Ratio 31.66

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 44,640 55,629
Giant (%) 15.53 19.21
Large (%) 41.16 38.04
Mid (%) 32.06 35.58
Small (%) 11.25 7.07
Tiny (%) -- 0.73

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
equal Sun Pharmaceutical Industries Healthcare 60.55 15.28 8.29 15.23
equal Cipla Healthcare 30.20 10.57 4.96 10.01
down Dr. Reddy's Lab Healthcare 33.38 12.03 4.40 9.97
equal Divi's Laboratories Healthcare 32.51 10.10 5.41 6.40
up Apollo Hospitals Healthcare 50.68 6.13 3.12 5.27
equal Torrent Pharmaceuticals Healthcare 63.13 5.69 2.65 5.22
equal Aurobindo Pharma Healthcare 11.53 7.11 0.00 4.29
equal Alkem Laboratories Healthcare 21.88 5.95 2.48 4.02
down Lupin Healthcare -- 9.24 0.86 3.91
up Fortis Healthcare Healthcare 32.01 3.86 0.00 3.83
equal Gland Pharma Healthcare 36.15 4.92 0.00 3.51
equal Biocon Healthcare 57.60 4.47 1.51 2.72
equal Zydus Wellness Consumer Staples 33.45 4.86 2.19 2.50
equal Sanofi India Healthcare 14.13 4.02 2.19 2.44
equal Indoco Remedies Healthcare 22.01 2.44 0.00 2.43
equal Ajanta Pharma Healthcare 22.45 2.33 0.00 2.33
equal Glaxosmithkline Pharma Healthcare 14.98 2.23 0.00 2.21
equal Eris Lifesciences Healthcare 21.90 3.16 0.66 2.01
equal Abbott India Healthcare 50.56 2.45 0.00 1.95
equal Ipca Laboratories Healthcare 26.18 4.11 0.00 1.87
equal Medplus Health Services Healthcare 94.02 2.12 0.00 1.86
equal Metropolis Healthcare Healthcare 34.05 5.05 1.61 1.66
equal Tarsons Products Healthcare 37.01 1.30 0.00 1.30
down Vijaya Diagnostic Centre Healthcare 33.02 1.92 0.00 0.93
down Solara Active Pharma Sciences Healthcare -- 2.08 0.00 0.19

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-May-2022

Fund Manager

— Dhaval Shah since 20-Jun-2019

Education: Mr.Shah has done B.Com. from University of Mumbai & MBA from Somaiya Institute of Management Studies & Research. He also holds CFA designation.

Experience: Prior to joining Aditya Birla Sunlife Mutual Fund he has worked with HDFC Mutual Fund, Reliance Mutual Fund, Morgan Stanley.

Funds Managed:


-0.06%

Change from previous, NAV as on 30-Jun-2022

Growth: ₹ 16.2600

IDCW: ₹ 13.8400


Investment Strategy

The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.

Investment Details

Min. Investment (₹) 1,000
Min. Addl Investment (₹) 1,000
Min. SIP Investment (₹) 500
Min. No of Cheques 6
Min. Withdrawal (₹) 1
Min. Balance (₹) 500
Lock-in Period Not Applicable
Exit Load 1% for redemption within 30 days

Basic Details

Fund House: Aditya Birla Sun Life Mutual Fund
Launch Date: 10-Jul-2019
Return Since Launch: 17.75%
Benchmark: S&P BSE Healthcare TRI
Riskometer: Very High
Type: Open-ended
Assets: ₹ 470 Cr (As on 31-May-2022)
Expense: 2.57% (As on 31-May-2022)
Risk Grade: --
Return Grade: --
Turnover: 59.00%

Most Recent Dividends

Plan Record Date Dividend (₹ / Unit)  
IDCW27-Sep-20211.2590

 30-Sep-20201.2800

Contact Information

AMC: Aditya Birla Sun Life AMC Ltd.

Address: One India Bulls Center - Tower 1, 17th Floor - Jupiter Mills Compound, 841 Senapati Bhawan, Elphinstone Road, Mumbai - 400013

Fax: 022-43568110

Website: http://mutualfund.adityabirlacapital.com

Registrar & Transfer Agent: Computer Age Management Services Ltd.

Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai - 600002

Phone: 1800-3010-6767 / 1800-419-7676

Fax: 044-30407101

Email: [email protected]

Website: www.camsonline.com

Upcoming Video

Investors' Hangout

All about nominations in mutual funds

DateFri, 08-Jul-2022
Time12:30 PM - 12:40 PM

attending You have reserved a spot